In the last trading session, 2.58 million Lyell Immunopharma Inc (NASDAQ:LYEL) shares changed hands as the company’s beta touched -0.61. With the company’s per share price at $3.01 changed hands at $0.35 or 13.16% during last session, the market valuation stood at $764.84M. LYEL’s last price was a discount, traded about -31.89% off its 52-week high of $3.97. The share price had its 52-week low at $1.32, which suggests the last value was 56.15% up since then. When we look at Lyell Immunopharma Inc’s average trading volume, we note the 3-month average coming to 901.66K.

Lyell Immunopharma Inc (NASDAQ:LYEL) trade information

Instantly LYEL was in green as seen at the end of in last trading. With action 44.02%, the performance over the past five days has been green. The jump to weekly highs of 3.14 added 13.16% to the stock’s daily price. The company’s shares are showing year-to-date upside of 55.15%, with the 5-day performance at 44.02% in the green. However, in the 30-day time frame, Lyell Immunopharma Inc (NASDAQ:LYEL) is 28.09% up.

Lyell Immunopharma Inc (LYEL) estimates and forecasts

Data shows that the Lyell Immunopharma Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 91.72% over the past 6 months, a 2.15% in annual growth rate that is considerably lower than the industry average of 9.40%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -15.28%. The 2024 estimates are for Lyell Immunopharma Inc earnings to increase by 8.52%, but the outlook for the next 5-year period is at -7.90% per year.